A Comparison of Placental Alpha Microglobuliun-1 Rapid Immunoassay and Standard Clinical Method For Diagnosis of Premature Rupture of Membranes

Authors

  • Idowu O Adebara​ Department of Obstetrics & Gynaecology, Federal Teaching Hospital, Ido Ekiti, Nigeria
  • Damilola Ifarinola Department of Obstetrics & Gynaecology, Federal Teaching Hospital, Ido Ekiti, Nigeria
  • Olumide Adewara College of Health Sciences, Afe Babalola University, Ado Ekiti, Nigeria
  • Adebayo Adeniyi College of Health Sciences, Afe Babalola University, Ado Ekiti, Nigeria
  • Ayobami O. Oni Department of Obstetrics & Gynaecology, Federal Teaching Hospital, Ido Ekiti, Nigeria
  • Gabriel Alayode Department of Internal Medicine, Federal Teaching Hospital, Ido Ekiti, Nigeria
  • Olusegun Busari Department of Internal Medicine, Federal Teaching Hospital, Ido Ekiti, Nigeria
  • Kolawole Fasakin Department of Haematology & Blood Transfusion Services, Federal Teaching Hospital, Ido Ekiti, Nigeria

DOI:

https://doi.org/10.21106/ijma.325

Keywords:

  • Placental,
  • Alpha macroglobulin-1,
  • Rapid immunoassay,
  • Clinical method,
  • Premature rupture of membranes

Abstract

Background/Objective:

Premature rupture of membranes (PROM) poses significant risk to the wellbeing of a pregnant woman and her fetus; the risk is more when not appropriately diagnosed and managed. The search for accuracy and increased specificity in diagnosis of PROM is an on-going process. The purpose of this study was to determine the accuracy of placental alpha microglobulin-1 (AmniSure ROM®) based test in detecting presence of amniotic fluid in cervico-vaginal secretions compared with standard clinical assessment in diagnosis of PROM in a rural tertiary hospital in South West, Nigeria. AmniSure ROM is a point of care test which is convenient to both the health care provider and patient; thus its use can shorten the turnaround time and improve patient care.

Methodology:

This was a cross-sectional study. All pregnant women with symptoms suggestive of PROM premature over a period of six months at the Federal Teaching Hospital, Ido Ekiti, south-west Nigeria, were recruited and evaluated using the standard clinical evaluation and AmniSure ROM®.

Results:

In all, 64 participants were recruited. Mean maternal age and gestational age at presentation were 29.6 ± 3.4 years and 37.2 ± 2.4 weeks respectively. AmniSure ROM® test was positive in 81.2% of the participants, while standard clinical test was positive in 71.9% of the participants. The two tests were positive in 70.3% of all evaluated participants. The sensitivity of AmniSure ROM in diagnosis of PROM was 97.8% compared to that obtained in standard clinical assessment. The negative predictive value of AmniSure ROM was 91.7%.

Conclusion and Global Health Implications:

Compared to standard clinical assessment, AmniSure ROM test was a more sensitive, rapid and accurate method for confirming the diagnosis of rupture of membrane. Its adoption in routine practice will reduce complications associated with delay and missed diagnosis following use of routine standard clinical assessment alone.

Downloads

Download data is not yet available.

Similar Articles

<< < 8 9 10 11 12 13 14 15 16 17 > >> 

You may also start an advanced similarity search for this article.

Downloads

Abstract Views: 2335
PDF Views/Downloads: 307
HTML Views/Downloads: 159

Published

2019-12-13
Dimensions Citation count:

How to Cite

O Adebara​, I., Ifarinola, D., Adewara, O., Adeniyi, A., O. Oni, A., Alayode, G., … Fasakin, K. (2019). A Comparison of Placental Alpha Microglobuliun-1 Rapid Immunoassay and Standard Clinical Method For Diagnosis of Premature Rupture of Membranes. International Journal of Maternal and Child Health and AIDS, 8(2), 156–162. https://doi.org/10.21106/ijma.325

License


Copyright © 2019 Idowu O Adebara​, Damilola Ifarinola, Olumide Adewara, Adebayo Adeniyi, Ayobami O. Oni, Gabriel Alayode, Olusegun Busari, Kolawole Fasakin. Published by Global Health and Education Projects, Inc., USA.

Creative Commons License

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License , which permits others to remix, transform, and build upon the work non-commercially, provided the original author is credited and the new creations are licensed under the same terms.